Cargando…

SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling

Dysfunction of the Hippo pathway enables cells to evade contact inhibition and provides advantages for cancerous overgrowth. However, for a significant portion of human cancer, how Hippo signaling is perturbed remains unknown. To answer this question, we performed a genome-wide screening for genes t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liang, Li, Peixue, Hao, Xue, Lu, Yi, Liu, Mingxian, Song, Wenqian, Shan, Lin, Yu, Jiao, Ding, Hongyu, Chen, Shishuang, Yang, Ailing, Zeng, Yi Arial, Zhang, Lei, Jiang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895894/
https://www.ncbi.nlm.nih.gov/pubmed/32661924
http://dx.doi.org/10.1007/s13238-020-00742-6
_version_ 1783653448954150912
author Xu, Liang
Li, Peixue
Hao, Xue
Lu, Yi
Liu, Mingxian
Song, Wenqian
Shan, Lin
Yu, Jiao
Ding, Hongyu
Chen, Shishuang
Yang, Ailing
Zeng, Yi Arial
Zhang, Lei
Jiang, Hai
author_facet Xu, Liang
Li, Peixue
Hao, Xue
Lu, Yi
Liu, Mingxian
Song, Wenqian
Shan, Lin
Yu, Jiao
Ding, Hongyu
Chen, Shishuang
Yang, Ailing
Zeng, Yi Arial
Zhang, Lei
Jiang, Hai
author_sort Xu, Liang
collection PubMed
description Dysfunction of the Hippo pathway enables cells to evade contact inhibition and provides advantages for cancerous overgrowth. However, for a significant portion of human cancer, how Hippo signaling is perturbed remains unknown. To answer this question, we performed a genome-wide screening for genes that affect the Hippo pathway in Drosophila and cross-referenced the hit genes with human cancer genome. In our screen, Prosap was identified as a novel regulator of the Hippo pathway that potently affects tissue growth. Interestingly, a mammalian homolog of Prosap, SHANK2, is the most frequently amplified gene on 11q13, a major tumor amplicon in human cancer. Gene amplification profile in this 11q13 amplicon clearly indicates selective pressure for SHANK2 amplification. More importantly, across the human cancer genome, SHANK2 is the most frequently amplified gene that is not located within the Myc amplicon. Further studies in multiple human cell lines confirmed that SHANK2 overexpression causes deregulation of Hippo signaling through competitive binding for a LATS1 activator, and as a potential oncogene, SHANK2 promotes cellular transformation and tumor formation in vivo. In cancer cell lines with deregulated Hippo pathway, depletion of SHANK2 restores Hippo signaling and ceases cellular proliferation. Taken together, these results suggest that SHANK2 is an evolutionarily conserved Hippo pathway regulator, commonly amplified in human cancer and potently promotes cancer. Our study for the first time illustrated oncogenic function of SHANK2, one of the most frequently amplified gene in human cancer. Furthermore, given that in normal adult tissues, SHANK2’s expression is largely restricted to the nervous system, SHANK2 may represent an interesting target for anticancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13238-020-00742-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7895894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Higher Education Press
record_format MEDLINE/PubMed
spelling pubmed-78958942021-03-05 SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling Xu, Liang Li, Peixue Hao, Xue Lu, Yi Liu, Mingxian Song, Wenqian Shan, Lin Yu, Jiao Ding, Hongyu Chen, Shishuang Yang, Ailing Zeng, Yi Arial Zhang, Lei Jiang, Hai Protein Cell Research Article Dysfunction of the Hippo pathway enables cells to evade contact inhibition and provides advantages for cancerous overgrowth. However, for a significant portion of human cancer, how Hippo signaling is perturbed remains unknown. To answer this question, we performed a genome-wide screening for genes that affect the Hippo pathway in Drosophila and cross-referenced the hit genes with human cancer genome. In our screen, Prosap was identified as a novel regulator of the Hippo pathway that potently affects tissue growth. Interestingly, a mammalian homolog of Prosap, SHANK2, is the most frequently amplified gene on 11q13, a major tumor amplicon in human cancer. Gene amplification profile in this 11q13 amplicon clearly indicates selective pressure for SHANK2 amplification. More importantly, across the human cancer genome, SHANK2 is the most frequently amplified gene that is not located within the Myc amplicon. Further studies in multiple human cell lines confirmed that SHANK2 overexpression causes deregulation of Hippo signaling through competitive binding for a LATS1 activator, and as a potential oncogene, SHANK2 promotes cellular transformation and tumor formation in vivo. In cancer cell lines with deregulated Hippo pathway, depletion of SHANK2 restores Hippo signaling and ceases cellular proliferation. Taken together, these results suggest that SHANK2 is an evolutionarily conserved Hippo pathway regulator, commonly amplified in human cancer and potently promotes cancer. Our study for the first time illustrated oncogenic function of SHANK2, one of the most frequently amplified gene in human cancer. Furthermore, given that in normal adult tissues, SHANK2’s expression is largely restricted to the nervous system, SHANK2 may represent an interesting target for anticancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13238-020-00742-6) contains supplementary material, which is available to authorized users. Higher Education Press 2020-07-13 2021-03 /pmc/articles/PMC7895894/ /pubmed/32661924 http://dx.doi.org/10.1007/s13238-020-00742-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Xu, Liang
Li, Peixue
Hao, Xue
Lu, Yi
Liu, Mingxian
Song, Wenqian
Shan, Lin
Yu, Jiao
Ding, Hongyu
Chen, Shishuang
Yang, Ailing
Zeng, Yi Arial
Zhang, Lei
Jiang, Hai
SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title_full SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title_fullStr SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title_full_unstemmed SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title_short SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
title_sort shank2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating hippo signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895894/
https://www.ncbi.nlm.nih.gov/pubmed/32661924
http://dx.doi.org/10.1007/s13238-020-00742-6
work_keys_str_mv AT xuliang shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT lipeixue shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT haoxue shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT luyi shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT liumingxian shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT songwenqian shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT shanlin shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT yujiao shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT dinghongyu shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT chenshishuang shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT yangailing shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT zengyiarial shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT zhanglei shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling
AT jianghai shank2isafrequentlyamplifiedoncogenewithevolutionarilyconservedrolesinregulatinghipposignaling